Earnings Call · Q2 FY2025·2025-08-08

Q2 25EPS +16.92%·Rev n/aQ1 25EPS -3.77%·Rev n/aQ4 24EPS +27.63%·Rev n/aQ3 24EPS +21.33%·Rev n/a⚠ consensus missing

LISATA THERAPEUTICS, INC. LSTA

David J. Mazzo — President and Chief Executive Officer

James Nisco — Financial Officer

Kristen K. Buck — Clinical Development Executive

−4.4%1d on move date−3.5% vs SPY3d−1.2%5d−4.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LSTA calls or request research access.

More LSTA calls Browse calls Request research access